Association of high plasma TNF-alpha levels and TNF-alpha/IL-10 ratios with TNF2 allele in severe P. falciparum malaria patients in Sri Lanka

References

• Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008;9(7):725–32.
   Web of Science ®Google Scholar
• Marsh K, Froster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, et al. Indicators of life threatening malaria in African children. N Engl J Med. 1995;332(21):1399–404.
   Web of Science ®Google Scholar
• Alles HK, Mendis KN, Carter R. Malaria mortality rates in South Asia and in Africa: implications for malaria control. Parasitol Today. 1998;14(9):369–75.
   Google Scholar
• Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet. 2005;77:171–90.
   PubMed Web of Science ®Google Scholar
• Normark J, Nilsson D, Ribacke U, Winter G, Moll K, Wheelock CE, et al. PfEMP1-DBL 1α amino acid motifs in severe disease states of Plasmodium falciparum malaria. Proc Natl Acad Sci USA. 2007;104(40):15835–40.
   Web of Science ®Google Scholar
• Kyes SA, Kraemer SM, Smith JD. Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene family. Eukaryot Cell. 2007;6(9):1511–20.
   Web of Science ®Google Scholar
• Kwiatkowski D, Hill AV, Sambaou I, Twumasi P, Castracane J, Manogue KR, et al. TNF concentration in fatal cerebral, non-fatal cerebral and uncomplicated Plasmodium falciparum malaria. Lancet. 1990;336:1201–4.
   PubMed Web of Science ®Google Scholar
• Day PJ, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT, et al. The prognostic and pathophysiologic role of pro- and anti-inflammatory cytokines in severe malaria. J Infect Dis. 1999;180:1288–97.
   PubMed Web of Science ®Google Scholar
• Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, et al. Serum level of the proinflammatory cytokines interleukin-1 beta (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12 (p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun. 2004;72(10):5630–7.
   Web of Science ®Google Scholar
• Clark IA, Budd AC, Alleva LM, Cowden WB. Human malarial disease: a consequence of inflammatory cytokine release. Malar J. 2006;5:85.
   PubMed Web of Science ®Google Scholar
• McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis. 1999;179:287–90.
   Web of Science ®Google Scholar
• Kwiatkowski D, Perlmann P. Inflammatory processes in the pathogenesis of malaria. In: Wahlgren M, Perlmann P, editors. Malaria: molecular and clinical aspects. 1st ed. Amsterdam: Harwood Academic Publishers; 1999, 329–361.
   Google Scholar
• Ramharter M, Kremsner PG, Willheim M, Winkler H, Graninger W, Winkler S. Plasmodium falciparum-specific interleukin-2 and tumor necrosis factor-alpha expressing-T cells are associated with resistance to reinfection and severe malaria in healthy African children. Eur Cytokine Netw. 2004;15(3):189–96.
   Web of Science ®Google Scholar
• Allan RJ, Beattie P, Bate C, Hensbroek MB, Morris-Jones S, Greenwood BM, et al. Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria. Infect Immun. 1995;63(4):1173–5.
   Web of Science ®Google Scholar
• Wilson AG, di Giovine FS, Blackmore AI, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNF-α) gene detectable by Ncol restriction of PCR product. Hum Mol Genet. 1992;1(5):353.
   PubMedGoogle Scholar
• Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, et al. Secretion of tumor necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol. 1996;43:456–63.
   PubMed Web of Science ®Google Scholar
• McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature. 1994;371:508–11.
   PubMed Web of Science ®Google Scholar
• Wattawidanage J, Carter R, Perera KL, Munasingha A, Bandara S, McGuinness D, et al. TNFα*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans. Clin Exp Immunol. 1999;115(2):350–5.
   Web of Science ®Google Scholar
• Li C, Corraliza I, Langhorne J. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect Immun. 1999;67(9):4435–42.
   Web of Science ®Google Scholar
• Ho M, White NJ. Molecular mechanisms of cytoadherence in malaria. Am J Physiol Cell Physiol. 1999;276:C1231–42.
   PubMed Web of Science ®Google Scholar
• Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol. 2005;77:3–15.
   PubMed Web of Science ®Google Scholar
• Penman B, Gupta S. Evolution of virulence in malaria. J Biol. 2008;7:22.
   PubMedGoogle Scholar
• Alles HK. Study of clinical aspects and pathophysiology of malaria and epidemiology of severe and complicated malaria [PhD thesis]. Colombo: University of Colombo; 1997.
   Google Scholar
• Pathirana SL, Alles HK, Bandara S, Phone-Kyaw M, Perera MK, Wickramasinghe AR, et al. ABO-blood-group types and protection against severe, Plasmodium falciparum malaria. Ann Trop Med Parasitol. 2005;99(2):119–24.
   Web of Science ®Google Scholar
• Pathirana SL, Ekanayeke K, Howard RJ, Mendis KN, Handunnetti SM. Cytoadherence and its association with clinical disease in Plasmodium falciparum infections in Sri Lanka. J Natl Sci Found Sri Lanka. 2010;38(4):233–40.
   Web of Science ®Google Scholar
• Warrell DA, Molyneux ME, Beales PF. Severe and complicated malaria. Trans Roy Soc Trop Med Hyg. 1990;84 (Suppl. 2):1–65.
   Web of Science ®Google Scholar
• Karunaweera ND, Carter R, Grau GE, Mendis KN. Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease. Am J Trop Med. 1998;58(2):204–10.
   Web of Science ®Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
   Google Scholar
• Sohail M, Kaul A, Bali P, Raziuddin M, Singh MP, Singh OP, et al. Alleles −308A and −1031C in the TNF-α gene promoter do not increase the risk but associated with circulating levels of TNF-α and clinical features of vivax malaria in Indian patients. Mol Immunol. 2008;45:1682–92.
   Web of Science ®Google Scholar
• Perera RA. Peripheral blood mononuclear cells and cytokine Profile in severe and uncomplicated malaria patients in Sri- Lanka [PhD thesis]. Colombo: University of Colombo; 2003.
   Google Scholar
• Herath NP. Human host genetic factors and cytokine responses associated with the pathogenesis of Plasmodium falciparum malarial disease [PhD thesis]. Colombo: University of Colombo; 2003.
   Google Scholar
• Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 1989;320:1586–91.
   PubMed Web of Science ®Google Scholar
• Peyron F, Burdin N, Ringwald JP, Vuillez F, Rousset F, Banchereau J. High levels of circulating IL-10 in human malaria. Clin Exp Immunol. 1994;95:300–3.
   PubMed Web of Science ®Google Scholar
• Baptista JL, Vanham G, Wery M, Marck EV. Cytokine levels during mild and cerebral malaria in children living in a mesoendemic area. Trop Med Int Health. 1997;2(7):673–9.
   Web of Science ®Google Scholar
• Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003;24(9):491–9.
   PubMed Web of Science ®Google Scholar
• Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, Frangos JA, et al. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med. 2006;12(12):1417–22.
   Web of Science ®Google Scholar
• Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN. Dynamics of fever and serum TNF levels are closely associated during clinical paroxysms in P. vivax malaria. Proc Natl Acad Sci USA. 1992;89:3200–3.
   PubMed Web of Science ®Google Scholar
• Kern P, Hemmer CJ, van Damme J, Gruss HJ, Dietrich M. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med. 1989;87(2):139–43.
   Web of Science ®Google Scholar
• May J, Lell B, Luty AJ, Meyer CG, Kremsner PG. Plasma interleukin-10: tumor necrosis factor (TNF)-α ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis. 2000;182:1570–3.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski D. Malarial toxins and the regulation of parasite density. Parasitol Today. 1995;11(6):206–12.
   Google Scholar
• Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM. Tumour necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol. 1989;77:361–6.
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal MR, Coffman RL, O’Garra A. Interleukin-10 and interleukin-10 receptor. Ann Rev Immunol. 2001;19:683–765.
   PubMed Web of Science ®Google Scholar
• Ho M, Schollaardt T, Snape S, Looareesuwan S, Suntharasamai P, White NJ. Endogenous interleukin-10 modulates pro-inflammatory response in Plasmodium falciparum malaria. J Infect Dis. 1998;178:520–5.
   PubMed Web of Science ®Google Scholar
• Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori DB, Oliver-Commey J, Nkrumah K, et al. Low plasma concentrations of interleukin-10 in severe malarial anemia compared with cerebral and uncomplicated malaria. Lancet. 1998;351(9118):1768–72.
   PubMed Web of Science ®Google Scholar
• Awandare GA, Goka B, Boeuf P, Tetteh JK, Kurtzhals JA, Behr C, et al. Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress. J Infect Dis. 2006;194:1438–46.
   Web of Science ®Google Scholar
• Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, Udhayakumara V. A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in Western Kenya. J Infect Dis. 1999;179:279–82.
   PubMed Web of Science ®Google Scholar
• Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, Riley EM. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis. 2002;185:971–9.
   PubMed Web of Science ®Google Scholar
• Kumaratilleke LM, Ferrante A, Rzepczyk CM. The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN: comparisons with tumor necrosis factor effects. J Immunol. 1991;146(2):762–7.
   Web of Science ®Google Scholar
• Wozencraft AO, Dockrell HM, Taverne J, Targett GA, Playfare JH. Killing of human malaria parasites by macrophage secretory products. Infect Immun. 1984;43(2):664–9.
   Web of Science ®Google Scholar
• Wilson AG, Gordon C, Di Giovine FS, de Vries N, van der Putte LB, Emery P, et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol. 1994;24(1):191–5.
   Web of Science ®Google Scholar
• Mergani A, Khamis AH, Haboor AB, Hashim E, Gumma M, Awadelseed B, et al. Lack of association between −308 tumor necrosis factor polymorphism and susceptibility to cerebral malaria among Central Sudanese children. Int J Genetics and Mol Biol. 2010;2(5):67–71.
   Google Scholar